Cumberland Pharmaceuticals (CPIX) EBT (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted EBT of -$3.1 million for Q1 2026, down 125.34% sequentially from -$1.4 million in Q4 2025, and down 350.2% YoY from $1.3 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) EBT (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported EBT for 17 years, with the latest figure at -$3.1 million in Q1 2026.
- Quarterly EBT fell 350.2% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 116.84% YoY) and the FY2025 annual result came in at -$2.8 million, up 56.53% from the prior year.
- EBT eased to -$3.1 million in Q1 2026 per CPIX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, EBT peaked at $1.3 million in Q1 2025 and troughed at -$6.3 million in Q4 2023.
- A 5-year average of -$1.4 million and a median of -$1.4 million in 2025 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2025: EBT sank 1155.12% in 2024, then jumped 166.31% in 2025.
- Over 5 years, EBT stood at -$2.4 million in 2022, then sank by 160.29% to -$6.3 million in 2023, then jumped by 68.8% to -$2.0 million in 2024, then grew by 28.92% to -$1.4 million in 2025, then slumped by 125.34% to -$3.1 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$3.1 million, -$1.4 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.10 Mn |
| Mar 31, 2026 | -3.14 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -729,536.00 |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | -1.96 Mn |
| Sep 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.89 Mn |
| Dec 31, 2023 | -6.28 Mn |
| Sep 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | 869,091.00 |
| Mar 31, 2023 | 179,224.00 |
| Dec 31, 2022 | -2.41 Mn |
| Sep 30, 2022 | -416,326.00 |
| Jun 30, 2022 | -1.36 Mn |
| Mar 31, 2022 | -1.40 Mn |
| Dec 31, 2021 | -4.38 Mn |
| Sep 30, 2021 | -1.58 Mn |